These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28761055)

  • 1. A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors.
    Chopra DA; Sapkota K; Irvine MW; Fang G; Jane DE; Monaghan DT; Dravid SM
    Sci Rep; 2017 Jul; 7(1):6933. PubMed ID: 28761055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
    Sapkota K; Irvine MW; Fang G; Burnell ES; Bannister N; Volianskis A; Culley GR; Dravid SM; Collingridge GL; Jane DE; Monaghan DT
    Neuropharmacology; 2017 Oct; 125():64-79. PubMed ID: 28709671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792.
    Sapkota K; Burnell ES; Irvine MW; Fang G; Gawande DY; Dravid SM; Jane DE; Monaghan DT
    Neuropharmacology; 2021 Dec; 201():108818. PubMed ID: 34610288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.
    Sapkota K; Dore K; Tang K; Irvine M; Fang G; Burnell ES; Malinow R; Jane DE; Monaghan DT
    Biochem Pharmacol; 2019 Jan; 159():140-153. PubMed ID: 30503374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic and structural determinants of NMDA receptor voltage-dependent gating and slow Mg2+ unblock.
    Clarke RJ; Glasgow NG; Johnson JW
    J Neurosci; 2013 Feb; 33(9):4140-50. PubMed ID: 23447622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethanol inhibition of constitutively open N-methyl-D-aspartate receptors.
    Xu M; Smothers CT; Trudell J; Woodward JJ
    J Pharmacol Exp Ther; 2012 Jan; 340(1):218-26. PubMed ID: 22005043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of ligand gating and opening of NMDA receptor.
    Chou TH; Epstein M; Fritzemeier RG; Akins NS; Paladugu S; Ullman EZ; Liotta DC; Traynelis SF; Furukawa H
    Nature; 2024 Aug; 632(8023):209-217. PubMed ID: 39085540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
    Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
    Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
    Yi F; Mou TC; Dorsett KN; Volkmann RA; Menniti FS; Sprang SR; Hansen KB
    Neuron; 2016 Sep; 91(6):1316-1329. PubMed ID: 27618671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
    Riou M; Stroebel D; Edwardson JM; Paoletti P
    PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computationally Discovered Potentiating Role of Glycans on NMDA Receptors.
    Sinitskiy AV; Stanley NH; Hackos DH; Hanson JE; Sellers BD; Pande VS
    Sci Rep; 2017 Apr; 7():44578. PubMed ID: 28378791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory and inhibitory D-serine binding to the NMDA receptor.
    Yovanno RA; Chou TH; Brantley SJ; Furukawa H; Lau AY
    Elife; 2022 Oct; 11():. PubMed ID: 36301074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
    Talukder I; Wollmuth LP
    J Gen Physiol; 2011 Aug; 138(2):179-94. PubMed ID: 21746848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain.
    Zhu S; Stroebel D; Yao CA; Taly A; Paoletti P
    Nat Struct Mol Biol; 2013 Apr; 20(4):477-85. PubMed ID: 23454977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.
    Lü W; Du J; Goehring A; Gouaux E
    Science; 2017 Mar; 355(6331):. PubMed ID: 28232581
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.